Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001354488-13-003018
Filing Date
2013-05-20
Accepted
2013-05-20 14:22:17
Documents
11
Period of Report
2013-03-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT ppch_10q.htm 10-Q 473703
2 CERTIFICATION ppch_ex311.htm EX-31.1 16577
3 CERTIFICATION ppch_ex312.htm EX-31.2 16519
4 CERTIFICATION ppch_ex321.htm EX-32.1 5955
5 CERTIFICATION ppch_ex322.htm EX-32.2 5937
  Complete submission text file 0001354488-13-003018.txt   1914422

Data Files

Seq Description Document Type Size
6 ppnc-20130331.xml EX-101.INS 135077
7 ppnc-20130331.xsd EX-101.SCH 23449
8 ppnc-20130331_cal.xml EX-101.CAL 39639
9 ppnc-20130331_def.xml EX-101.DEF 19749
10 ppnc-20130331_lab.xml EX-101.LAB 139023
11 ppnc-20130331_pre.xml EX-101.PRE 94744
Mailing Address PO BOX 114 CAMBERWELL, VICTORIA C3 3124
Business Address PO BOX 114 CAMBERWELL, VICTORIA C3 3124 61 3 9208 4128
Propanc Health Group Corp (Filer) CIK: 0001517681 (see all company filings)

EIN.: 300662986 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-54878 | Film No.: 13857787
SIC: 2834 Pharmaceutical Preparations